EUVIMEDEUVIMED entdecken
Crossref

Potential for omitting sentinel lymph node biopsy in patients with human epidermal growth factor receptor 2-positive or triple negative breast cancer with non-breast pCR after neoadjuvant chemotherapy

Dong Seung Shin, Jiwon Park, Hyunwoo Lee, Woong Ki Park, Se Kyung Lee, Byung Joo Chae, Jonghan Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Hee Jun Choi, Jai Min Ryu

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.110331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Dong Seung Shin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Triple Negative Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Research Foundation of Korea, National Cancer Center, Samsung Medical Center, Sungkyunkwan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sentinel Lymph Node BiopsyTriple Negative Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesBreast NeoplasmsHumansFemaleNeoadjuvant TherapyMiddle AgedRetrospective StudiesAdultAxillaAgedNeoplasm, ResidualChemotherapy, AdjuvantNeoplasm StagingLymphatic MetastasisMastectomy

Stichwörter der Autor:innen

Breast neoplasmNeoadjuvant chemotherapyPathologic complete responseSentinel lymph node biopsy

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
  • Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: sheol1981@naver.com.

Förderung

  • National Research Foundation of Korea
  • National Cancer Center
  • Samsung Medical Center, Sungkyunkwan University
  • Korea Ministry of Health and Welfare

Zitieren

APA

Shin, D. S., Park, J., Lee, H., Park, W. K., Lee, S. K., Chae, B. J., Yu, J., Lee, J. E., Kim, S. W., Nam, S. J., Choi, H. J., & Ryu, J. M. (2025). Potential for omitting sentinel lymph node biopsy in patients with human epidermal growth factor receptor 2-positive or triple negative breast cancer with non-breast pCR after neoadjuvant chemotherapy. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110331

Vancouver

Shin DS, Park J, Lee H, Park WK, Lee SK, Chae BJ, et al. Potential for omitting sentinel lymph node biopsy in patients with human epidermal growth factor receptor 2-positive or triple negative breast cancer with non-breast pCR after neoadjuvant chemotherapy. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110331

BibTeX
@article{Shin2025,
  author = {Shin, Dong Seung and Park, Jiwon and Lee, Hyunwoo and Park, Woong Ki and Lee, Se Kyung and Chae, Byung Joo and Yu, Jonghan and Lee, Jeong Eon and Kim, Seok Won and Nam, Seok Jin and Choi, Hee Jun and Ryu, Jai Min},
  title = {Potential for omitting sentinel lymph node biopsy in patients with human epidermal growth factor receptor 2-positive or triple negative breast cancer with non-breast pCR after neoadjuvant chemotherapy},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.110331}
}
Kostenlos starten →